
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics primarily for mental health. The company leverages its expertise in epigenetics, RNA editing, artificial intelligence, neuroscience, and psychiatry to create precision psychiatry solutions. Its key products include EDIT-B®, a blood test differentiating unipolar depression from bipolar disorder, EDITOX®, a cell-based solution mimicking drug impact on RNA editing, and the EDITECH® platform integrating RNA/DNA sequencing with AI. ALCEDIAG's approach is protected by seven patent families and supported by a global network of key opinion leaders. The company is engaged in rigorous R&D, clinical validation, and collaborates with academic and industry partners to ensure medical efficacy and practical clinical use. It aims to transform mental health diagnostics with objective, dynamic biomarkers and AI-driven tools, addressing unmet needs in mental health diagnosis and patient management.

ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics primarily for mental health. The company leverages its expertise in epigenetics, RNA editing, artificial intelligence, neuroscience, and psychiatry to create precision psychiatry solutions. Its key products include EDIT-B®, a blood test differentiating unipolar depression from bipolar disorder, EDITOX®, a cell-based solution mimicking drug impact on RNA editing, and the EDITECH® platform integrating RNA/DNA sequencing with AI. ALCEDIAG's approach is protected by seven patent families and supported by a global network of key opinion leaders. The company is engaged in rigorous R&D, clinical validation, and collaborates with academic and industry partners to ensure medical efficacy and practical clinical use. It aims to transform mental health diagnostics with objective, dynamic biomarkers and AI-driven tools, addressing unmet needs in mental health diagnosis and patient management.